Patient-Preference Data in Medical Devices to Take Center Stage at ISPOR-FDA Summit

January 31, 2020

An upcoming summit hosted by the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) in conjunction with the Food and Drug Administration (FDA) is set to focus on using patient-preference data in regulatory decision making for medical devices.

The summit, “Using Patient-Preference Information in Medical Device Regulatory Decisions: Benefit-Risk and Beyond,” is set for March 31 at the FDA White Oak Campus in Silver Spring, Maryland.

“Patient-preference information is increasingly being used in regulatory decision making for medical devices,” ISPOR says in a press release. “The ISPOR-FDA Summit will provide a forum to engage key stakeholders … to discuss and explore the role, challenges, and opportunities of using patient-preference information across the healthcare ecosystem.”

To learn more about this event, click here.

Click here to read the full press release.

Share This Story!